Salbutamol hemisulfate F-03716556 InChi: InChI=1S/C17H17N7/c18-16-21-10-13(15(23-16)9-11-1-2-11)14-5-8-20-17(24-14)22-12-3-6-19-7-4-12/h3-8

InChi: InChI=1S/C17H17N7/c18-16-21-10-13(15(23-16)9-11-1-2-11)14-5-8-20-17(24-14)22-12-3-6-19-7-4-12/h3-8

3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl] furan-2

Beigelman L

An examination of the psychometric properties of the community integration questionnaire (CIQ) in spinal cord injury

3 microM) in cells

Salbutamol hemisulfate F-03716556 InChi: InChI=1S/C17H17N7/c18-16-21-10-13(15(23-16)9-11-1-2-11)14-5-8-20-17(24-14)22-12-3-6-19-7-4-12/h3-8Salbutamol Hemisulfate (Albuterol hemisulfate) is a short acting 2 adrenergic receptor agonist Target: 2 Adrenergic Receptor Salbutamol Hemisulfate (Albuterol hemisulfate) is a short acting, selective beta2 adrenergic receptor agonist used in the treatment of asthma and COPD. All the effects of R, S salbutamol on guinea pig skeletal muscles are due to the activity of the R enantiomer. Thus there is a common enantiomeric profile for the skeletal muscle